25.08.2023 | Article

eHCPs in the Netherlands say smoking cessation is more critical than lung…

What eHCPs in the Netherlands are conversing about online within lung cancer

By Mary Kangley

27.09.2023 | Webinars

Digital Opinion Leaders in Lung Cancer – Identify, Engage & Activate

Never before seen insights from HCPs’ online conversations in Lung Cancer.

By Anni Neumann and Mary Kangley

On-Demand | Webinars

The beginner’s guide to how HCPs use Twitter, TikTok, Instagram and LinkedIn

For anyone in the pharma industry who would like to understand the behaviour of HCPs online

By Mary Fletcher-Louis and Mary Kangley

On-Demand | Webinars

The beginner’s guide to DOLs

For anyone in a pharmaceutical company who is new to the concept of a Digital Opinion Leader

By Mary Fletcher-Louis and Mary Kangley

07.03.2023 | Article

Leading women are at the forefront of the oncology digital space

CREATION.co celebrates 5 female Digital Opinion Leaders Oncologists.

By Mary Kangley

Header Image for CREATION.co research on RSV

08.12.2022 | Article

HCPs take front row seat to the Pharma race for an RSV…

The early data findings of the RSV Vaccine by pharma companies is drawing HCPs' interest...

By Mary Kangley

29.07.2022 | Article

HCPs use Twitter to improve clinical trial design, recruitment and equity

While a field of its own, clinical trial design and recruitment can present a number of...

By Mary Kangley

14.07.2022 | Article

Bowel babe: The lasting impact of Dame Deborah James’ bowel cancer journey

Since the beginning of her journey, Deborah James (Bowel Babe) shared the most intimate...

By Mary Kangley

20.05.2022 | Article

The challenges facing new drug treatment in Alzheimer’s Disease

There are currently around 900K people living with the disease in the UK...

By Mary Kangley

26.01.2022 | Article

Why HCPs love TikTok: #MedTok the new #MedTwitter

HCPs use TikTok to combat misinformation and share accurate medical information...

By Mary Kangley

Article Header: The most discussed products by HCPs in relation to the fight against Omicron

22.12.2021 | Press Release

Positive trial data sees GSK’s Xevudy and Pfizer’s PAXLOVID as most mentioned…

Positive trial data sees GSK’s Xevudy most mentioned treatment in global Omicron fight...

By Mary Kangley

01.11.2021 | Article

Top 50 Pharma Tracker: Pfizer most discussed company with booster and children’s…

Discover what healthcare professionals (HCPs) think about children's COVID-19 jabs

By Mary Kangley

02.08.2021 | Article

What HCPs Think about Health Equity in Cancer Care

By Mary Kangley

01.08.2021 | Article

HCPs discuss “booster shot” to decrease the high spread of the Delta…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Mary Kangley

01.07.2021 | Article

HCPs discuss effectiveness of COVID-19 vaccines against Delta strain.

By Mary Kangley

16.12.2020 | Article

Scafell Pike: “an absurd post-quarantine activity, but very meaningful for the team!”

The CREATION team go climbing on the Scafell Pike; a meaningful activity for the team

By Mary Kangley

02.12.2020 | Article

Top 50 Pharma Tracker: Vaccine success dwarfs all other conversation

Discover what healthcare professionals (HCPs) think about Top 50 Pharmaceutical companies

By Mary Kangley

05.11.2020 | Article

Women Supporting Women: Women In Medicine Month a Social Media Success

"Women in Medicine: Advancing Equity, Creating Change”

By Mary Kangley